- Home
- NPCE vs MBAV Comparison
NPCE vs MBAV Comparison
Compare NPCE & MBAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- MBAV
- Stock Information
- Founded
- NPCE 1997
- MBAV 2024
- Country
- NPCE United States
- MBAV United States
- Employees
- NPCE N/A
- MBAV N/A
- Industry
- NPCE Medical Specialities
- MBAV
- Sector
- NPCE Health Care
- MBAV
- Exchange
- NPCE Nasdaq
- MBAV NYSE
- Market Cap
- NPCE 358.3M
- MBAV 368.4M
- IPO Year
- NPCE 2021
- MBAV 2024
- Fundamental
- Price
- NPCE $17.68
- MBAV $10.45
- Analyst Decision
- NPCE Buy
- MBAV
- Analyst Count
- NPCE 6
- MBAV 0
- Target Price
- NPCE $14.67
- MBAV N/A
- AVG Volume (30 Days)
- NPCE 332.4K
- MBAV 143.3K
- Earning Date
- NPCE 05-13-2025
- MBAV 01-01-0001
- Dividend Yield
- NPCE N/A
- MBAV N/A
- EPS Growth
- NPCE N/A
- MBAV N/A
- EPS
- NPCE N/A
- MBAV 0.24
- Revenue
- NPCE $84,306,000.00
- MBAV N/A
- Revenue This Year
- NPCE $20.74
- MBAV N/A
- Revenue Next Year
- NPCE $12.47
- MBAV N/A
- P/E Ratio
- NPCE N/A
- MBAV $43.99
- Revenue Growth
- NPCE 22.05
- MBAV N/A
- 52 Week Low
- NPCE $5.45
- MBAV $9.97
- 52 Week High
- NPCE $18.98
- MBAV $10.91
- Technical
- Relative Strength Index (RSI)
- NPCE 74.11
- MBAV N/A
- Support Level
- NPCE $16.50
- MBAV N/A
- Resistance Level
- NPCE $18.98
- MBAV N/A
- Average True Range (ATR)
- NPCE 1.27
- MBAV 0.00
- MACD
- NPCE 0.46
- MBAV 0.00
- Stochastic Oscillator
- NPCE 83.37
- MBAV 0.00
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About MBAV M3-BRIGADE ACQUISITION V CORP
M3-Brigade Acquisition V Corp is a blank check company.